B

휴온스글로벌

084110KOSDAQ의약품 제조업

56.3 / 100

Reference Date: 2026-04-13

Financial Score20.0 / 40
News Sentiment18.3 / 25
Momentum6.0 / 20
Disclosure12.0 / 15
AI Analysis: ROE significantly exceeds the industry average but Operating Profit is on a declining trend. Plunged 30.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Hyunohs Global is a holding company under the Hyunohs Group, managing 13 subsidiaries across pharmaceuticals, medical devices, biopharmaceuticals, and health supplements. Key operations include Hyunohs' pharmaceutical manufacturing, Hyunmedics' botulinum toxin and filler development, Hyunohs Biopharma's biopharmaceutical research, and Hyunohs Meditech's medical device production. Primary revenue streams include brand royalties and dividends from subsidiaries.

Number of Employees

121people

Average Salary

62.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
22.01Industry Average 14.803.0Point

Higher than industry avg (caution)

PBR
0.60Industry Average 1.045.5Point

Lower than industry avg (good)

ROE
7.96Industry Average 4.425.5Point

1.8x industry avg (good)

Debt Ratio
13.66Industry Average 11.982.0Point

Higher than industry avg (caution)

Trend 2023~20254.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲5.7% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼10.8% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 8.7% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 3Neutral 1Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position3.0Point

52w lower range (31%)

Current 52,100Won52-week high 75,30052-week low 41,400
1-month return0.0Point

1m -30.81% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

9 totalPositive 1Neutral 8Negative 0
  • Positive배당락2026-04-01
  • Neutral정기주주총회결과2026-03-31
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
  • Neutral[첨부정정]사업보고서 (2025.12)2026-03-24
  • Neutral사업보고서 (2025.12)2026-03-23